1. Home
  2. TARS vs PFS Comparison

TARS vs PFS Comparison

Compare TARS & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$60.71

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Provident Financial Services Inc

PFS

Provident Financial Services Inc

HOLD

Current Price

$22.24

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
PFS
Founded
2016
1839
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
TARS
PFS
Price
$60.71
$22.24
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$89.00
$23.75
AVG Volume (30 Days)
614.2K
741.6K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
4.28%
EPS Growth
48.21
112.38
EPS
N/A
0.61
Revenue
$451,360,000.00
$73,109,000.00
Revenue This Year
$56.43
$0.68
Revenue Next Year
$30.19
$5.97
P/E Ratio
N/A
$36.72
Revenue Growth
146.71
7.06
52 Week Low
$38.51
$15.92
52 Week High
$85.25
$23.98

Technical Indicators

Market Signals
Indicator
TARS
PFS
Relative Strength Index (RSI) 41.92 52.27
Support Level $60.38 $21.53
Resistance Level $67.24 $22.96
Average True Range (ATR) 3.45 0.41
MACD 0.03 0.00
Stochastic Oscillator 34.38 63.95

Price Performance

Historical Comparison
TARS
PFS

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: